Oral Manifestations of Immunodeficiency
Immunodeficiency presents with distinct oral manifestations that vary by the specific immune component affected: T-cell deficiencies primarily cause oral candidiasis and herpetic infections, B-cell deficiencies lead to bacterial infections and dental caries, while phagocytic defects result in severe periodontal disease. 1
Pattern Recognition by Immune Defect Type
T-Cell Deficiencies
- Oral candidiasis (most common)
- Recurrent herpetic infections
- Severe viral infections of oral mucosa
- These patients require prophylaxis for Pneumocystis jirovecii pneumonia and consideration for viral prophylaxis 2
B-Cell/Humoral Deficiencies
- Dental caries (increased susceptibility) 3
- Bacterial infections of oral cavity
- Aphthous-like ulceration (seen in 73% of CVID patients) 4
- Pseudomembranous candidiasis
- Enamel hypoplasia 4
Phagocytic Deficiencies
- Severe plaque-induced periodontal disease (hallmark finding) 3
- Early-onset aggressive periodontitis 5
- Periodontal tissue destruction from impaired bacterial clearance 6
Specialized Immunodeficiency Syndromes
- Apoptosis defects: Structural tooth abnormalities 3
- DNA repair defects: Oral squamous cell carcinoma risk 3
Clinical Approach to Diagnosis
When encountering oral lesions that persist beyond 2 weeks or fail to respond to 1-2 weeks of treatment, biopsy should be considered 7. However, blood testing is mandatory before biopsy to exclude contraindications and provide diagnostic clues 7:
Essential pre-biopsy workup:
- Full blood count (screens for blood system diseases, anemia, leukemia)
- Coagulation studies
- Fasting blood glucose
- HIV antibody
- Syphilis serology 7
Management Considerations
Antimicrobial Therapy
Standard antimicrobial regimens are inadequate for immunocompromised patients 2. Key principles:
- Use aggressive, prolonged courses
- Consider early combined antimicrobial therapy
- Implement prophylactic strategies 2
Prophylaxis Regimens for Bacterial Respiratory/Oral Infections
Common options include 2:
- Amoxicillin: 10-20 mg/kg daily or twice daily (children); 500-1,000 mg daily or twice daily (adults)
- Trimethoprim/sulfamethoxazole: 5 mg/kg daily or twice daily (children); 160 mg daily or twice daily (adults)
- Azithromycin: 10 mg/kg weekly (children); 500 mg weekly (adults)
IgG Replacement Monitoring
For patients receiving immunoglobulin therapy, monitor every 6-12 months 2:
- IgG trough levels
- Blood cell counts
- Serum chemistry
Critical Pitfalls
Avoid permanent central venous access solely for IVIG administration 2. With subcutaneous immunoglobulin options available, the infection risk of indwelling catheters outweighs benefits for patients requiring only periodic infusions.
IgA-deficient patients have anaphylaxis risk with IVIG (though rare), potentially from IgG anti-IgA antibodies reacting with IgA contamination in IVIG products 2. Some patients tolerate subcutaneous IgG after IVIG anaphylaxis 2.
Distinguishing Features
The oral cavity manifestations directly reflect which immune component is defective 1:
- Fungal/viral infections → T-cell problem
- Bacterial infections/caries → B-cell problem
- Severe periodontitis → Phagocyte problem
This pattern recognition allows clinicians to suspect specific immunodeficiency categories based on oral presentation alone, though definitive diagnosis requires immunological testing 6, 5.